Bicyclic heterocyclic derivatives as MNK1 and MNK2 modulators and uses thereof

Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate

Heterocyclic compounds for the treatment of arenavirus

Methods of treating cochlear synaptopathy

SHP2 phosphatase inhibitors and methods of use thereof

FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS

ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS

Pharmaceutical compositions for sustained or delayed release

Imidazopiperazine inhibitors of transcription activating proteins

Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor

Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders

Methods of treating schizophrenia and depression

Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor

Cyclic peroxides as prodrugs for selective delivery of agents

N-[(2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3] oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide having HIV integrase inhibitory activity

Pteridine dione monocarboxylate transporter inhibitors

Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitors

Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitors

Use of c-Met Inhibitors to Treat Cancers Harbouring MET Mutations

4-imidazopyridazin-1-yl-benzamides as Btk inhibitors

METHOD OF TREATING INSOMNIA

Bruton's tyrosine kinase inhibitors

Intranasal DHE for the Treatment of Headache

Heterocyclic inhibitors of PTPN11

USE OF SELECTIVE GABA A ALPHA 5 NEGATIVE ALLOSTERIC MODULATORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM CONDITIONS

Pyrazolo [3,4-d] pyrimidine derivative

ORAL FORMULATIONS MIMETIC OF ROUX-EN-Y GASTRIC BYPASS ACTIONS ON THE ILEAL BRAKE; COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS AND SYSTEMS FOR TREATMENT OF METABOLIC SYNDROME MANIFESTATIONS INCLUDING INSULIN RESISTANCE, FATTY LIVER DISEASE, HYPERLIPIDEMIA, AND TYPE 2 DIABETES

Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereof

METHODS OF TREATMENT

Combination of ABCG2 inhibitors with sacituzumab govitecan (IMMU-132) overcomes resistance to SN-38 in Trop-2 expressing cancers

SGC stimulators

Oxazolidinone compounds and methods of use thereof as antibacterial agents

FILM DOSAGE FORMS CONTAINING AMORPHOUS ACTIVE AGENTS

METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE

Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions

Compounds and compositions for inhibition of FASN

Compounds and compositions for inhibition of FASN

Triazolopyrazine

Combination treatment for the regenerative therapy of type 1 diabetes mellitus patients

Polycyclic-carbamoylpyridone compounds and their pharmaceutical use

Methods of treating RBP4 related diseases with triazolopyridines

Bicyclic heterocyclic compound

COMPOSITIONS COMPRISING TIMOLOL AND AN ANTI-INFLAMMATORY AGENT

PHOSPHODIESTERASE INHIBITOR TREATMENT

Treatment of congenital adrenal hyperplasia

Organic compounds

Methods and compositions for treating cancer

Methods of Blocking the CXCR-4/SDF-1 Signaling Pathway With Inhibitors of Bruton's Tyrosine Kinase

HIGH DRUG LOAD POLYMERIC NANOPARTICLE FORMULATIONS AND METHODS OF MAKING AND USING SAME

Compositions and Methods for Treating Metabolic Diseases

Oral Capsule Composite Formulation of Dutasteride and Tadalafil

Composite Formulation of Dutasteride and Tadalafil Comprising Glycerol Fatty Acid Ester Derivative or Propylene Glycol Fatty Acid Ester Derivative and Oral Capsule Formulation Comprising the Same

NOVEL USES

Substituted bicyclic compounds as bromodomain inhibitors

Imidazopyrazinamine phenyl derivative and use thereof

Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor

Use of Sigma-1 receptor agonist compounds

COMPOUNDS FOR TREATMENT OF FIBROSIS DISEASES

USE OF A DPP-4 INHIBITOR IN SIRS AND/OR SEPSIS

Treatment of cancers having alterations within the SWI/SNF chromatin remodeling complex

SLEEP IMPROVING AGENT

Use of levocetirizine and montelukast in the treatment of autoimmune disorders

PYRAZOLE CARBOXAMIDE COMPOUNDS AND METHODS OF USE

INHIBITORS OF JUN N-TERMINAL KINASE

Inhibitors of influenza virus replication, application methods and uses thereof

Amorphous solid dispersions

Therapeutic heterocyclic compounds

COMPOSITIONS, KITS AND METHODS FOR TREATING TYPE II DIABETES MELLITUS

METHODS FOR PREPARING ACTIVE EXTRACT AND APPLICATION THEREOF

Methods and materials for treating calcific aortic valve stenosis

Methods and compositions for sleep disorders and other disorders

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Use of CDK8 inhibitors to treat diseases of inflammation and autoimmunity

DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE

4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors

Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor to treat b-cell proliferative disorders

PARTICULATE MATERIALS

Organic compounds

PHARMACEUTICAL FORMULATIONS, PROCESSES FOR PREPARATION, AND METHODS OF USE

Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects

Method of treating metabolic disorders and depression with dopamine receptor agonists

METHODS FOR IMPROVING RESISTANCE TO SKELETAL MUSCLE FATIGUE

PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION WITH CONTROLLED DISSOLUTION RATE COMPRISING SUSTAINED-RELEASE PELLETS CONTAINING TAMSULOSIN HYDROCHLORIDE

Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect

Methods for treating skeletal muscle cachexia arising from burn injury by administering PDE4B-selective inhibitors

6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors

Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation

POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY

Chemokine receptor modulators and uses thereof

Therapeutic compounds and uses thereof

Treatment and prevention of atherothrombosis by inhibition of bruton's tyrosine kinase (BTK)

Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat Rb-positive tumors

TREATMENT OF ALCOHOLISM AND DEPRESSION AND/OR DYSPHORIC MOOD USING IBUDILAST

BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same

Regimens and compositions for treating HIV infections and AIDS

Compounds for treatment of cancer

SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease

Ovarian cancer vaccines

K-RAS MUTATIONS AND ANTAGONISTS

Treatment of addiction and impulse-control disorders using PDE7 inhibitors

Anticancer agents

Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodegenerative diseases

Carboxamide derivatives useful as rsk inhibitors

Substituted dipyrido[1,2-a:1′,2′-d]pyrazines for treating viral infections

Double-layer tablet and painkiller tablet with same structure

Hypnotics tablet with double-layer structure

INHIBITORS OF HEPATITIS C VIRUS REPLICATION

COMPOSITE CAPSULE PREPARATION CONTAINING TADALAFIL AND TAMSULOSIN AND HAVING IMPROVED STABILITY AND ELUTION RATE

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

Imidazopyridines Syk inhibitors

NOVEL COMPOSITIONS AND METHODS

Fused heterotricyclic organic compounds, pharmaceutical compositions, and medical uses thereof

COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS

TREATMENT FOR DIABETES IN PATIENTS INAPPROPRIATE FOR METFORMIN THERAPY

Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof

Systems pharmacology for treating ocular disorders

CHEWABLE DOSAGE FORMS CONTAINING SITAGLIPTIN AND METFORMIN

Chewable dosage forms containing sitagliptin and metformin

Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazocines and methods for treating viral infections

TARGETING PARP1 FOR TREATMENT OF TSC AND CANCERS

Methods using HDAC11 inhibitors

Methods using HDAC11 inhibitors

Treatment of erectile dysfunction and other indications

Therapeutic Compositions

Small molecules inhibitors of RAD51

Orally Disintegrating Tablet Formulation For Enhanced Bioavailability

Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl) butan-1-one for inhibiting serotonin reuptake transporter activity

Veterinary composition comprising imidacloprid, moxidectin and praziquantel for cutaneous topical application (spot on), for the treatment and prevention of ecto and endoparasitoses affecting dogs

Organic compounds

RAPIDLY DISINTEGRATING TABLET COMPOSITIONS OF DPP-IV INHIBITORS WITH LOW MINERAL CONTENT

Biaryl derivative and medicine containing same

ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS

Nitrogen-containing heterocycle and carbocycle derivatives having TrkA inhibitory activity

METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS

POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE

COMPOUNDS FOR THE TREATMENT OF MALARIA

Use of Gaboxadol in the treatment of diabetes and related conditions

PREVENTION OF VASCULAR AND CARDIAC FIBROSIS VIA IRE1ALPHA INHIBITION

HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF

PHOSPHODIESTERASE INHIBITOR TREATMENT

Methods of measuring signaling pathway activity for selection of therapeutic agents

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-alpha]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer

Therapeutic Combinations of a BTK Inhibitor and a GITR Binding Molecule, a 4-1BB Agonist, or an OX40 Agonist

Liposome formulation for delivery of Wnt signal pathway inhibitor

Anti-EGFR combinations for treating tumors

Small molecule IRE1-α inhibitors

TRPA1 modulators

Positive allosteric modulators of the GLP-1 receptor

Salt of quinolone compound, polymorphs thereof, preparation method therefor, composition, and applications

COMPOSITIONS AND METHODS FOR LIPID METABOLISM DISORDER

Therapeutic Combinations of an Antifolate and a BTK Inhibitor

Agent for preventing and/or treating Alzheimer's disease

Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor

Inhibitors of hepatitis C virus

TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN

NASAL DOSAGE FORMS OF DIHYDROERGOTAMINE

6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection

METHODS OF TREATMENT USING PYRIDINONYL PDK1 INHIBITORS

Compounds and compositions for inhibition of FASN

BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment

TREATMENT OF CANCER WITH DNAPK INHIBITORS

Methods for the preparation of biologically active compounds in nanoparticulate form

Hexahydropyrazinotriazinone derivatives as kinase inhibitors

Tetrahydropyridopyrazine modulators of GPR6

COMPOUNDS, COMPOSITIONS AND METHODS OF AGELASTATIN ALKALOIDS

Methods of treating RBP4 related diseases with triazolopyridines

Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors

Pharmaceutical compound

Uses of DPP IV inhibitors

Anti-PD-L1 combinations for treating tumors

Heterocyclic compounds

Pharmaceutical formulation for bedwetting and method of use thereof

EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF

AZASPIRO DERIVATIVES AS TRPM8 ANTAGONISTS

Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging

Compositions for treating neurological disorders

Cooperative Medication Combination Systems

METHOD OF TREATING A PATIENT WITH A CYP3A4 SUBSTRATE DRUG

Method of treating a patient with a CYP3A4 substrate drug

Substituted imidazo[1,2-a]pyrazines as Syk inhibitors

1,3,4,8-Tetrahydro-2H-Pyrido[1,2-a]Pyrazine Derivative and Use of the Same as HIV Integrase Inhibitor

Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their use

Ferroportin inhibitors

INHIBITORS OF JUN N-TERMINAL KINASE

Methods of treating muscular dystrophy

METHODS OF USE OF INHIBITORS OF PHOSPHODIESTERASES AND MODULATORS OF NITRIC OXIDE, REACTIVE OXYGEN SPECIES, AND METALLOPROTEINASES IN THE TREATMENT OF PEYRONIE'S DISEASE, ARTERIOSCLEROSIS AND OTHER FIBROTIC DISEASES

Methods of Using BTK Inhibitors to Treat Dermatoses

Imidazopyrazine inhibitors of Bruton's tyrosine kinase

Benzopiperazine compositions as BET bromodomain inhibitors

Fused indazole pyridone compounds as antivirals

Glucokinase activator compositions for the treatment of diabetes

COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES

COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING MUCOSITIS AND WEIGHT LOSS

Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors

COMT inhibiting methods and compositions

Synergistic compositions

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Intermediate compounds for preparation of praziquantel and processes for preparing the intermediate compounds

Ferroportin inhibitors

Combinations

Survivin-targeting anti-tumor agents and uses thereof

OXAZOLIDINONE COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS

FUSED IMIDAZOLE COMPOUNDS

Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions

NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat

Treatment of addiction and impulse-control disorders using PDE7 inhibitors

ISOQUINOLINES AS INHIBITORS OF HPK1

LINEAR POLYSACCHARIDE BASED FILM PRODUCTS

SYK INHIBITORS

Non-hydrophobic compounds for use in treating metastasis and/or cartilage defect

Compositions and methods for treating toxoplasmosis, cryptosporidiosis and other apicomplexan protozoan related diseases

Bumped kinase inhibitor compositions and methods for treating cancer

Transmucosal and subcutaneous compositions

TREATMENT FOR DIABETES IN PATIENTS INAPPROPRIATE FOR METFORMIN THERAPY

Polycyclic pyridone derivative having integrase inhibitory activity

Substituted triazolopiperazine PARP inhibitor, preparation method therefor and use thereof

Bromocriptine formulations

Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor

Methods of treating muscular dystrophy

Substituted cyclopropanes as PDE-10 inhibitors

6,7-dihydropyrazolo[1,5-α]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors

PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES

Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors

Target for treating hepatitis B virus

Compositions comprising macrocycle derivatives incorporating bridged macrocycles and methods of producing and using same

Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a CDK4/6 Inhibitor

Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor

Methods, compositions, and uses of novel Fyn kinase inhibitors

Pyrido-azaheterecydic compound and preparation method and use thereof

Aminoindazole derivatives as sodium channel inhibitors

Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols

MESOSCALE NANOPARTICLES FOR SELECTIVE TARGETING TO THE KIDNEY AND METHODS OF THEIR THERAPEUTIC USE

Optogenetic inhibition of overactive neuronal activity

N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders

Treatment of cancer with TOR kinase inhibitors

Combination therapies for treatment of spinal muscular atrophy

Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors

Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication

Process for the preparation of triazole and salt thereof

cGAS antagonist compounds

Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy

FIXED-DOSE COMBINATIONS OF ANTIVIRAL COMPOUNDS

Indazolyl-oxo-isothiazole compounds

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Agents for use in the treatment of glioma

Method of treating insomnia

Substituted benzoxazepine for cancer therapy

Compounds and methods for CDK8 modulation and indications therefor

Tyrosine amide derivatives as Rho-kinase inhibitors

BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF

Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide

Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor and/or a JAK-2 Inhibitor

Urea derivative or pharmacologically acceptable salt thereof

Respiratory formulations and compounds for use therein

Methods

ANTIVIRAL THERAPY

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-(trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use

Substituted Tetrahydroquinolinone Compounds as ROR Gamma Modulators

CHEWABLE COMPOSITION COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT

NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders

Compounds for the treatment of HIV

Methods of Blocking the CXCR-4/SDF-1 Signaling Pathway With Inhibitors of Bruton's Tyrosine Kinase

Thienopyridine derivative for the treatment of hepatitis C infections

Ultra low dose doxepin and methods of using the same to treat sleep disorders

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-#a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-#carboxamide and solid state forms thereof

Inhibitors of protein kinases

Quinoxaline derivatives useful as FGFR kinase modulators

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them

Antibacterial compounds

Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy

TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS AND PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BHP

PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF

Combination methods and compositions including sleep therapeutics for treating mood

Tunable endogenous protein degradation

Pyridone and aza-pyridone compounds and methods of use

4-imidazopyridazin-1-yl-benzamides as BTK inhibitors

Substituted pyrazoles as JAK inhibitors

Glucagon-like peptide 1 modulator and uses thereof

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses

Heterocyclic compounds for treating psoriasis

COMPOSITIONS AND METHODS FOR THE REDUCTION OR PREVENTION OF HEPATIC STEATOSIS

Nanoparticle Composition and Methods for Synthesis Thereof

Anti-pulmonary tuberculosis nitroimidazole derivative

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluorethyl)pyrrolidine-1-carboxamide and solid state forms thereof

TETRACYCLIC AUTOTAXIN INHIBITORS

Bicyclic bromodomain inhibitors

Pharmaceutical formulation containing tadalafil

Tetracyclic heterocycle compounds useful as HIV integrase inhibitors

POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE

Aza spiro alkane derivatives as inhibitors of metalloproteases

SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS

METHOD OF TREATING NEUROLOGICAL DISORDER BY ENHANCING OUTGROWTH OF NEURITE

Therapeutic Compositions

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-alpla]pyrrolo[2,3-e]-pyrazin-8-YL)-N-(2,2,2-Trifluoroethyl)pyrrol and solid state forms thereof

Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders